MORTALITY AMONG CRITICALLY ILL PATIENTS WITH COVID-19 WHO RECEIVED TOCILIZUMAB

被引：0
|
作者：
Kruer, Rachel [1 ]
Tran, Mya [2 ]
Pollander, Abby [2 ]
Fadel, William [3 ,4 ]
Desai, Armisha [2 ]
机构：
[1] Indiana Univ Hlth, Indianapolis, IN USA
[2] Indiana Univ Hlth, Methodist Hosp, Indianapolis, IN USA
[3] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46204 USA
[4] Sch Med, Indianapolis, IN USA
来源：
CRITICAL CARE MEDICINE | 2022年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
252
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
    Gupta, Shruti
    Wang, Wei
    Hayek, Salim S.
    Chan, Lili
    Mathews, Kusum S.
    Melamed, Michal L.
    Brenner, Samantha K.
    Leonberg-Yoo, Amanda
    Schenck, Edward J.
    Radbel, Jared
    Reiser, Jochen
    Bansal, Anip
    Srivastava, Anand
    Zhou, Yan
    Finkel, Diana
    Green, Adam
    Mallappallil, Mary
    Faugno, Anthony J.
    Zhang, Jingjing
    Velez, Juan Carlos Q.
    Shaefi, Shahzad
    Parikh, Chirag R.
    Charytan, David M.
    Athavale, Ambarish M.
    Friedman, Allon N.
    Redfern, Roberta E.
    Short, Samuel A. P.
    Correa, Simon
    Pokharel, Kapil K.
    Admon, Andrew J.
    Donnelly, John P.
    Gershengorn, Hayley B.
    Douin, David J.
    Semler, Matthew W.
    Hernan, Miguel A.
    Leaf, David E.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 41 - 51
  • [2] EVALUATION OF THE EFFICACY OF TOCILIZUMAB IN CRITICALLY ILL COVID-19 PATIENTS
    Riggs, Kayla
    Patel, Vishal
    Pittiglio, Marina
    Cavanaugh, Joseph
    Sullivan, Jesse
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 141 - 141
  • [3] Tocilizumab in critically ill COVID-19 patients: An observational study
    Mushtaq, Muhammad Z.
    Mahmood, Saad B. Z.
    Almas, Aysha
    Wasti, Syed Ather
    Ali, Syed Ahsan
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 102
  • [4] Hispanic ethnicity and mortality among critically ill patients with COVID-19
    Ricardo, Ana C.
    Chen, Jinsong
    Toth-Manikowski, Stephanie M.
    Meza, Natalie
    Joo, Min
    Gupta, Shruti
    Lazarous, Deepa G.
    Leaf, David E.
    Lash, James P.
    [J]. PLOS ONE, 2022, 17 (05):
  • [5] Efficacy of tocilizumab in critically ill COVID-19 patients: a retrospective cohort
    Sadaf, Sairah
    Bashir, Babar
    Haider, Syeda Sabahat
    Mustafa, Ghulam
    Naqvi, Syed Aushtar Abbas
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (03) : 295 - 302
  • [6] PHARMACOKINETIC INFLUENCE OF TOCILIZUMAB ON MIDAZOLAM IN CRITICALLY ILL PATIENTS WITH COVID-19
    Mefford, Breanne
    Donaldson, Chris
    Bissell, Brittany
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 114 - 114
  • [7] EVALUATION OF TOCILIZUMAB ON CLINICAL OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19
    Swartwood, Claire
    Miller, Christopher
    North, Michael
    Roshon, Michael
    Wedoff, Abigail
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 216 - 216
  • [8] Sarcopenia and Mortality in Critically Ill COVID-19 Patients
    Yakti, Fatima Al Zahra
    Abusalah, Lana
    Ganji, Vijay
    [J]. LIFE-BASEL, 2024, 14 (01):
  • [9] Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
    Burger, B.
    Epps, S.
    Cardenas, V. M.
    Meena, N. K.
    Jagana, R.
    Atchley, W. T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19
    Keene, Adam B.
    Admon, Andrew J.
    Brenner, Samantha K.
    Gupta, Shruti
    Lazarous, Deepa
    Leaf, David E.
    Gershengorn, Hayley B.
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2022, 37 (04) : 500 - 509
12345